Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1999;99:2290-2294

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Furutani, M.
Right arrow Articles by Matsuoka, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Furutani, M.
Right arrow Articles by Matsuoka, R.
Related Collections
Right arrow Arrhythmias, clinical electrophysiology, drugs
Right arrow Genetics of cardiovascular disease

(Circulation. 1999;99:2290-2294.)
© 1999 American Heart Association, Inc.


Clinical Investigation and Reports

Novel Mechanism Associated With an Inherited Cardiac Arrhythmia

Defective Protein Trafficking by the Mutant HERG (G601S) Potassium Channel

Michiko Furutani, BS; Matthew C. Trudeau, PhD; Nobuhisa Hagiwara, MD, PhD; Akiko Seki, MD; Qiuming Gong, MD, PhD; Zhengfeng Zhou, MD, PhD; Shin-ichiro Imamura, DVM, PhD; Hirotaka Nagashima, MD, PhD; Hiroshi Kasanuki, MD; Atsuyoshi Takao, MD; Kazuo Momma, MD; Craig T. January, MD, PhD; Gail A. Robertson, PhD; Rumiko Matsuoka, MD, PhD

From the Department of Pediatric Cardiology (M.F., A.T., K.M., R.M.), Department of Cardiology (N.H., A.S., H.N., H.K.), and Research Division (S.I.), The Heart Institute of Japan, Tokyo Women's Medical University, Tokyo, Japan, and Department of Physiology (M.C.T., G.A.R.) and Section of Cardiology, Department of Medicine (Q.G., Z.Z., C.T.J.), University of Wisconsin, Madison, Wis.

Correspondence to Rumiko Matsuoka, MD, PhD, Department of Pediatric Cardiology, The Heart Institute of Japan, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo 162, Japan. E-mail rumiko{at}imcir.twmu.ac.jp


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Background—The congenital long-QT syndrome (LQTS) is an inherited disorder characterized by a prolonged cardiac action potential and a QT interval that leads to arrhythmia. Mutations in the human ether-a-go-go–related gene (HERG), which encodes the rapidly activating component of the delayed rectifier current (IKr), cause chromosome 7–linked LQTS (LQT2). Studies of mutant HERG channels in heterologous systems indicate that the mechanisms mediating LQT2 are varied and include mutant subunits that form channels with altered kinetic properties or nonfunctional mutant subunits. We recently reported a novel missense mutation of HERG (G601S) in an LQTS family that we have characterized in the present work.

Methods and Results—To elucidate the electrophysiological properties of the G601S mutant channels, we expressed these channels in mammalian cells and Xenopus oocytes. The G601S mutant produced less current than wild-type channels but exhibited no change in kinetic properties or dominant-negative suppression when coexpressed with wild-type subunits. To examine the cellular trafficking of mutant HERG channel subunits, enhanced green fluorescent protein tagging and Western blot analyses were performed. These showed deficient protein trafficking of the G601S mutant to the plasma membrane.

Conclusions—-Our results from both the Xenopus oocyte and HEK293 cell expression systems and green fluorescent protein tagging and Western blot analyses support the conclusion that the G601S mutant is a hypomorphic mutation, resulting in a reduced current amplitude. Thus, it represents a novel mechanism underlying LQT2.


Key Words: genes • arrhythmia • long-QT syndrome


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Long-QT syndrome (LQTS) is characterized by prolongation of the QT interval and is an inheritable, autosomal-dominant susceptibility to cardiac arrhythmias. LQTS was originally identified clinically as a lengthened QT interval on the ECG that can lead to torsade de pointes, syncope, and sudden death.1 2 Recent findings have led to advances in the understanding of the genetic basis of LQTS. Four ion channel genes are now associated with LQTS, and mutations have been discovered within these genes.3 4 5 6 7 8 One of these genes, HERG, encodes a component of the cardiac rapidly activating delayed rectifier current, IKr, which helps terminate the cardiac action potential.9 10 11 12 A reduction in IKr causes delayed repolarization13 and increased risk of LQTS.

Existing mechanisms by which mutations in HERG are thought to cause LQTS are diverse. They include a gene dosage effect in which the mutant subunits are not expressed and therefore do not affect wild-type subunits on coexpression or a dominant-negative effect in which the mutant subunit suppresses wild-type function on coassembly. Some mutations alter channel kinetics when expressed alone or with wild-type subunits, and this can be coupled with dominant-negative suppression.14 15 We recently reported that a glycine-to-serine mutation at position 601 in HERG (G601S) is present in an LQTS family.16 This mutation is located in the extracellular loop between the S5 domain and the pore domain (Figure 1ADown). In the present work, we show that the G601S mutant expresses less current than wild-type channels but exhibits no dominant-negative suppression of wild-type subunits and has no apparent alteration in gating kinetics. A large percentage of the G601S mutant channels do not traffic to the plasma membrane. Thus, this mutant represents a novel mechanism of altering currents in vivo, reduced expression levels.



View larger version (37K):
[in this window]
[in a new window]
 
Figure 1. G601S mutant expressed in HEK293 cells. A, G601S mutation lies in extracellular region between S5 and pore domain. B through E, Currents from wild-type HERG-transfected cells. F through I, Currents from G601S-transfected cells. From holding potential of -80 mV, current traces were elicited by 3-second depolarizing pulses between -40 and 0 mV (B and F) and between 10 and 50 mV (C and G). Tail current was recorded at -40 mV. I-V relationship obtained at end of depolarizing pulse revealed characteristic inward rectification (D and H), and I-V relationship for peak tail current amplitude showed voltage dependence of activation (E and I). J, Confocal-imaged GFP tagging of G601S and wild-type HERG channels in HEK293 cells. Left, Merged images of Nomarski with GFP fluorescence; right, GFP fluorescence images. GFP-WT signal was present intracellularly in endoplasmic reticulum and perinuclear space and in plasma membrane (florescent circular image). Unstained region within cell is nucleus. For GFP-G601S, signal was present intracellularly but with reduced plasma membrane signal. K, Western blot showing HERG-WT and G601S mutant proteins.


*    Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Generation of the G601S Expression Construct
The G601S mutant construct was generated by reverse transcriptase–polymer chain reaction from an LQTS patient carrying the mutation. The polymerase chain reaction product was subcloned into an HERG/pcDNA3 expression construct. The insert region, including the cloning sites, was sequenced directly. Also, HERG sequence was inserted downstream of the coding region of an enhanced green fluorescent protein (GFP), cloned in a pEGFP-C2 vector (CLONETECH). The first ATG was 57 bp downstream of the final GFP codon. The insert region, including the cloning sites, was sequenced directly.

Transfection and Voltage Clamp of HEK293 Cells
For expression in mammalian cells, we used the human embryonic kidney 293 cells (HEK293, ATCC No. CRL-1573). The cells were cultured to 60% to 70% confluence in a 35-mm tissue culture plate and were transfected with the lipofectamine method (Gibco-BRL) with 2.5 µg of the following: wild-type HERG/pcDNA3, G601S HERG/pcDNA3, the GFP-tagged wild-type HERG (GFP-WT), G601S mutant HERG (GFP-G601S), and pEGFP-C2. Electrical recording was performed 48 hours after initiation of transfection. The whole-cell voltage-clamp method used was the same as that described previously.17 18 19 Experiments were performed at room temperature. The membrane capacitance was 17.4±3.1 pF (n=11 cells) in wild-type HERG and 16.9±2.1 pF (n=8 cells, values represent mean±SEM) in the G601S mutant; these values were not significantly different among these 2 groups (2-way Student's t test, P>0.05). The normal Tyrode's solution contained the following (in mmol/L): NaCl 136.9, KCl 5.4, CaCl2 1.8, NaH2PO4 0.33, glucose 5, and HEPES 5 (pH adjusted to 7.4 with NaOH). The standard pipette solution contained (in mmol/L) KOH 110, KCl 20, EGTA 10, MgCl2 2, K2-ATP 5, K2-creatine phosphate 5, and HEPES 5 (pH 7.4 with aspartic acid, {approx}60 mmol/L).

Voltage Clamp of Xenopus Oocytes
RNA was prepared from 1 µg of template DNA in the pGH19 expression vector20 by use of T7 RNA polymerase from the message machine kit (Ambion). DNase 1 was then used to remove the template, and RNA was precipitated with 7.5 mol/L LiCl. The concentration of the purified RNA was then determined spectrophotometrically. The RNA was diluted with sterile water to yield {approx}2.5 ng RNA per injection at a volume of 36.8 nL. Cells injected with 1.25 ng RNA were injected with 18.4 nL of the same batch of RNA. Oocytes were stored at 18°C in ND-96 solution21 supplemented with 1 mmol/L gentamycin and 1 mg/mL BSA.

Two-electrode voltage clamp recordings were performed at room temperature 1 to 4 days after injection as previously described.11 The external bath solution contained (in mmol/L) KCl 5, NaCl 95, CaCl2 0.3, MgCl2 1.0, and HEPES 5, pH 7.4.

Laser Confocal Microscopy
Cells were cultured for 36 to 48 hours after transfection and photographed at 660x magnification under a microscope (LSM510, Zeiss). Confocal analysis was performed with an argon-krypton laser. Cells were observed after being treated with 0.1% trypsin (which causes the cells to become round) and resuspended in PBS.

Western Blot Analysis
Western blot analysis was performed as previously described.12 22 The membrane proteins were subjected to SDS-PAGE. They were then electrophoretically transferred onto nitrocellulose membranes. The nitrocellulose membranes were incubated with the HERG antifusion protein antibody (1:20 000 dilution) at room temperature overnight, and the antibody was detected with an ECL detection kit. The HERG antibody and its specificity have been previously described.22


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
*Results
down arrowDiscussion
down arrowReferences
 
Expression of HERG (G601S) Mutant Channels in HEK293 Cells
Figure 1Up compares the basic properties of HERG-WT and G601S mutant channels expressed in HEK293 cells. Figure 1BUp and 1CUp show HERG-WT currents elicited by depolarizing pulses between -40 and 0 mV (Figure 1BUp) and 10 and 50 mV (Figure 1CUp) from a holding potential of -80 mV. The outward current was activated in response to test potentials to >-50 mV and then progressively decreased with test potentials of >0 mV (Figure 1DUp). The amplitude of the tail current at -40 mV saturated at {approx}10 mV (Figure 1CUp). The current-voltage (I-V) relationships revealed that the peak outward current decreased at potentials positive to 10 mV, reflecting the inward rectifying property caused by the fast inactivation of HERG current (Figure 1DUp).9 23 The voltage dependence of channel activation was obtained by measuring the relative amplitude of the tail current as a function of test potentials. The voltage of half-maximal activation (V0.5) was -18.80±0.18 mV, and the slope factor was 8.46±0.10 mV per e-fold change in conductance in HERG-WT (Figure 1EUp). The current density was quantified by measurement of the tail currents at -40 mV after a 3-second depolarizing test pulse to 20 mV. Currents were normalized for plasma membrane surface area by cell capacitance, giving a current density of 63.1±5.5 pA/pF (n=11 cells) in HERG-WT. The corresponding properties of G601S mutant current in HEK293 cells are shown in Figure 1FUp through 1I. G601S also showed characteristic inwardly rectifying outward current similar to HERG-WT, but the current density of 9.8±0.7 pA/pF (n=8 cells) in G601S mutant is only 15.5% of the HERG-WT current. The voltage dependence of channel activation was similar to that of HERG-WT, with an V0.5 of -17.90±0.11 mV and a slope factor of 8.38±0.15 mV per e-fold change in conductance in G601S mutant. These results indicated that the voltage dependence and kinetics of the G601S mutant were similar to those of HERG-WT channels, except that its current density was substantially smaller and inactivation at the most positive voltages was slightly greater.

GFP Tagging and Western Blot Analyses
To examine the cellular trafficking of mutant HERG channel subunits, GFP was tagged to the N-terminus of HERG subunits and was expressed in HEK293 cells. As shown in Figure 1JUp, a strong confocal fluorescence signal associated with GFP-WT was present in the endoplasmic reticulum, perinuclear space, and plasma membrane. In contrast, a weak confocal fluorescence signal associated with GFP-G601S was seen in the plasma membrane, whereas a strong confocal signal was present in the endoplasmic reticulum and perinuclear space. The GFP-tagged G601S mutant HERG channels produced current on patch clamping of these cells (data not shown). In addition, the fluorescence signal associated with pEGFP-C2 was seen in the cytoplasm (data not shown).

We also investigated the Western blot analysis of the expression of HERG-WT and G601S mutant HERG channel protein in transiently transfected HEK293 cells (Figure 1KUp). The HERG-WT shows 2 bands of HERG proteins, a weaker upper broad band with a molecular mass of {approx}155 kDa and a stronger lower band with a molecular mass of {approx}135 kDa. For G601S mutant HERG protein, only a lower band ({approx}135 kDa) was present.

Expression of Mutant HERG (G601S) and Coexpression With HERG-WT in Xenopus Oocytes
We used the Xenopus oocyte expression system to confirm our results in the HEK293 cells and to test for a dominant-negative phenotype. Our results with Xenopus oocytes are consistent with those in cultured cells, with the G601S mutant producing less current than HERG-WT channels. Injection of identical amounts of RNA resulted in G601S mutant currents that were {approx}39% smaller than wild-type currents (Figure 2ADown, 2BDown, and 2FDown; 2-way Student's t test, P<0.001). The smaller currents from G601S channels are not obviously due to alteration of channel gating mechanisms, because the steady-state voltage dependence of activation (Figure 2CDown) and inactivation (Figure 2DDown and 2EDown) are identical to those of wild-type HERG channels. The V0.5 was -30.15 ± 0.15 mV with a slope factor of 10.34±0.13 (millivolts per e-fold change in conductance) for wild type (mean±SEM; n=10 cells) compared with a V0.5 of -29.30 ± 0.21 mV and slope factor of 9.80±0.19 for the mutant (n=7 cells). Differences in V0.5 between the oocytes and the HEK293 cells are attributable to differences in external Ca2+ used in the 2 preparations. The V0.5 of the steady-state inactivation curve was -76.17±0.99 mV with a slope factor of 19.96±0.84 for wild-type channels (n=9 cells) compared with a V0.5 of -78.89±0.81 mV and a slope factor of 20.09±0.69 for the G601S mutant channels (n=7 cells). The midpoints and slope factors of the mutant channels are not significantly different from the corresponding parameters of the wild-type channels (2-way Student's t test, P>0.05).



View larger version (41K):
[in this window]
[in a new window]
 
Figure 2. Coexpression of HERG-WT and G601S mutant channels in oocytes. Families of currents evoked from oocytes were injected with 2.5 ng wild-type RNA (A) and G601S RNA (B). C, Steady-state conductance-voltage (g/gmax versus V) relation for HERG-WT and G601S mutant channels was determined from analysis of tail currents. Tails were elicited by repolarization to -100 mV after 1-second pulses from -120 to 70 mV in 10-mV steps from holding potential of -100 mV (inset, B). Tail currents were fit with y=A1e-t/{tau}1+A2e-t/{tau}2 and extrapolated to onset of repolarizing pulse to correct for fast recovery from inactivation visible as monoexponential rising phase in tails. Extrapolated values were plotted versus voltage and fit with single-power Boltzmann function of form y=1-[1/1+e(V-V0.5)/k]. D and E, Steady-state inactivation relation was obtained for HERG-WT and G601S mutant by use of 3-pulse voltage protocol (D, inset). Channels were fully activated by 1-second pulse to 40 mV, followed by 30-ms conditioning pulses to range of voltages from 70 to -150 mV, during which channels equilibrated between open and inactive state. Number of channels in open state was reported by subsequent pulse to 40 mV.23 Resulting instantaneous current (D, arrow) was plotted versus voltage (after correction for closing at hyperpolarized potentials23 ) and fit with single-power Boltzmann function {1/[1 + e(V-V0.5)/k]}. All data in Figure 2Up is from same batch of oocytes because different batches of cells expressed different amounts of current. All were recorded 48 hours after injection.

We tested for a dominant-negative suppression of HERG expression by the G601S mutant using a quantitative coinjection approach in oocytes. Care was taken to ensure that the resulting current expressed was roughly proportional to the amount of RNA injected at the 2 concentrations. Doubling the amount of RNA injected from 1.25 to 2.5 ng resulted in a 78% increase from 2503±161 (n=10 cells) to 4457±215 (n=16 cells) nA for wild-type currents and a 75% increase from 1581±133 (n=10 cells) to 2771±214 (n=10 cells) nA for G601S currents. If the G601S mutant exhibits dominant-negative suppression, the currents produced by coinjection of wild-type and G601S RNA should produce currents smaller than expected from summation of currents expressed singly in oocytes from the corresponding amounts of RNA. As illustrated in Figure 2FUp, the currents from coinjected oocytes (4023±214 nA, n=11 cells) are as expected from an additive effect of the 2 RNA species alone (ie, 2503 nA+1581 nA=4084 nA) and indicate that the G601S mutant subunit does not interact in a dominant-negative manner with HERG.


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
*Discussion
down arrowReferences
 
The G601S mutant channel phenotype is a reduction in current. Evidence in support of this conclusion includes the reduced current amplitude of G601S compared with wild-type channels in 2 heterologous expression systems, persistence of normal gating mechanisms in mutant channels, and lack of a dominant-negative interaction of mutant with wild-type subunits. Instead, the G601S mutant phenotype may be the result of fewer channels in the plasma membrane.

To date, the phenotypes of several chromosome 7–linked LQTS (LQT2) mutations have been characterized by expression of the mutant HERG channels in heterologous systems,14 15 22 24 and more studies of other mutants are expected. Electrophysiological studies have shown that some mutations cause loss of or altered channel function. Some mutations also cause dominant-negative suppression of HERG-WT channels or may shift the voltage dependence of channel inactivation.14 24 Recently, HERG-WT and LQT2 protein processing has been studied through biochemical approaches.12 22 These studies showed that HERG-WT generates 2 protein bands on Western blot: the upper band represents the mature protein that forms functional channels in the surface membrane, whereas the lower band represents immature protein in the endoplasmic reticulum.22 Furthermore, some LQT2-associated HERG mutations generated different patterns on Western blot: 2 mutations (Y611H and V822 M) caused defects in the biosynthesis of HERG channels with the protein retained in the endoplasmic reticulum; 2 other mutations (I593R and G628S) were processed similarly to HERG-WT protein, but the mutations did not produce functional channels; and 1 mutation (T474I) was processed similarly to the wild-type protein and expressed HERG current with altered gating properties. These findings suggested that the loss of HERG channel function in LQT2 mutations is caused by multiple mechanisms, including abnormal channel processing, generation of nonfunctional channels, and altered channel gating, as well as by dominant-negative suppression of HERG-WT current.

In the present work, the G601S mutation represents another mechanism for LQT2. As shown in Figures 1BUp through 1I and 2, this mutation produces current that is similar to HERG-WT current but with reduced amplitude. The GFP-tagging and Western blot data in Figure 1JUp and 1KUp show that G601S mutant protein is generated as the immature protein within the endoplasmic reticulum but that very little is processed to the mature form of the protein. Hence, for the G601S mutant, very little GFP-tagged protein is visible in the plasma membrane, and the amount of mature protein in the transiently transfected cells is insufficient to be detected on the Western blot. Thus, the G601S mutation is the first example of a trafficking-deficient, normal-gating mutant HERG channel. Similar findings have been observed with hypomorphic mutations with altered protein trafficking in CFTR channels.25

The extent of G601S mutant expression compared with that of HERG-WT is markedly different in the 2 heterologous expression systems. In HEK293 cells, the mutant expression level was only {approx}15% relative to HERG-WT, whereas in Xenopus oocytes, the mutant expressed {approx}61% of the current seen with HERG-WT. The reason for this difference in current amplitudes is unknown, but it may be attributable to temperature-dependent differences in levels of protein expression in HEK293 cells, which are incubated at 37°C, compared with the oocytes, which are incubated at 18°C. Mutant CFTR ion channel proteins show a temperature-dependent increase in protein expression as incubation temperatures are lowered from 37°C to 23°C.25 Whether a similar dependence of G601S mutant expression on temperature accounts for the differences exhibited between the heterologous systems will require further experimentation.

The reduction in current observed on expression of LQT2-associated mutations in HERG suggests that a reduction in native IKr causes susceptibility to cardiac arrhythmia. The reduction in expression of the G601S mutant, which is in the extracellular loop between S5 and the pore domain, is a less severe phenotype than those previously described for other mutations located in other domains, which have either gene dosage or dominant-negative effects. It will be interesting to determine whether the degree of HERG channel dysfunction correlates with the severity of the disease state.


*    Acknowledgments
 
This work was supported by an open research grant (1996 and 1997) from the Japan Research Promotion Society for Cardiovascular Diseases and Welfare, grants from the Japan Shipbuilding Industry Foundation (1996 and 1997), a predoctoral fellowship from the American Heart Association of Wisconsin (Dr Trudeau), an American Heart Association Established Investigator Award, and NIH grant HL-55973-03 (Dr Robertson), an American Heart Association Scientist Development Award (Dr Zhou), and the Oscar Rennabohm Foundation.


*    Footnotes
 
M. Furutani and M.C. Trudeau contributed equally to this work.

Received October 28, 1998; revision received January 20, 1999; accepted February 4, 1999.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
up arrowDiscussion
*References
 

  1. Romano C. Congenital cardiac arrhythmia. Lancet. 1965;1:658–659.[Medline] [Order article via Infotrieve]
  2. Ward OC. A new familial cardiac syndrome in children. J Ir Med Assoc. 1964;54:103–106.[Medline] [Order article via Infotrieve]
  3. Wang Q, Curran ME, Splawski I, Burn TC, Millholland JM, VanRaay TJ, Shen J, Timothy KW, Vincent GM, de Jager T, Schwartz PJ, Towbin JA, Moss AJ, Atkinson DL, Landes GM, Connors TD, Keating MT. Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat Genet. 1996;12:17–23.[Medline] [Order article via Infotrieve]
  4. Curran ME, Splawski I, Timothy KW, Vincent GM, Green ED, Keating MT. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell. 1995;80:795–803.[Medline] [Order article via Infotrieve]
  5. Splawski I, Tristani-Firouzi M, Lehmann MH, Sanguinetti MC, Keating MT. Mutations in the hminK gene cause long QT syndrome and suppress Iks function. Nat Genet. 1997;17:338–340.[Medline] [Order article via Infotrieve]
  6. Wang Q, Shen J, Splawski I, Atkinson D, Li Z, Robinson JL, Moss AJ, Towbin JA, Keating MT. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell. 1995;80:805–811.[Medline] [Order article via Infotrieve]
  7. Yamagishi H, Furutani M, Kamisago M, Morikawa Y, Kojima Y, Hino Y, Furutani Y, Kimura M, Imamura S, Takao A, Momma K, Matsuoka R. A de novo missense mutation (R1623Q) of the SCN5A gene in a Japanese girl with sporadic long QT syndrome. Hum Mutat [serial online]. 1997;mutation in brief 140. http://journals.wiley.com/1059-7794/ humuann.htm.
  8. Splawski I, Timothy KW, Vincint GM, Atkinson DL, Keating MT. Molecular basis of the long QT syndrome associated with deafness. N Engl J Med. 1997;336:1562–1567.[Free Full Text]
  9. Trudeau MC, Warmke JW, Ganetzky B, Robertson GA. HERG: a human inward rectifier in the voltage-gated potassium channel family. Science. 1995;269:92–95.[Abstract/Free Full Text]
  10. Sanguinetti MC, Jiang C, Curran ME, Keating MT. A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel. Cell. 1995;81:299–307.[Medline] [Order article via Infotrieve]
  11. London B, Trudeau MC, Newton KP, Beyer AK, Copeland NG, Gilbert DJ, Jenkins NA, Satler CA, Robertson GA. Two isoforms of the mouse ether-a-go- go–related gene coassemble to form channels with properties similar to the rapidly activating component of the cardiac delayed rectifier K+ current. Circ Res. 1997;81:870–878.[Abstract/Free Full Text]
  12. Zhou Z, Gong Q, Ye B, Fan Z, Makielski JC, Robertson GA, January CT. Properties of HERG channels stably expressed in HEK293 cells studied at physiological temperature. Biophys J. 1998;74:230–241.[Abstract/Free Full Text]
  13. Sanguinetti MC, Jurkiewicz NK. Two components of cardiac delayed rectifier K+ current. J Gen Physiol. 1990; 96:195–215.
  14. Sanguinetti MC, Curran ME, Spector PS, Keating MT. Spectrum of HERG K+ channel dysfunction in an inherited cardiac arrhythmia. Proc Natl Acad Sci U S A. 1996;93:2208–2212.[Abstract/Free Full Text]
  15. Li X, Xu J, Li M. The human {Delta}1261 mutation of the HERG potassium channel results in a truncated protein that contains a subunit interaction domain and decreases the channel expression. J Biol Chem. 1997;272:705–708.[Abstract/Free Full Text]
  16. Akimoto K, Furutani M, Imamura S, Furutani Y, Kasanuki H, Takao A, Momma K, Matsuoka R. Novel missense mutation (G601S) of HERG in a Japanese long QT syndrome family. Hum Mutat [serial online]. 1997;mutation in brief 75. http://journals.wiley.com/1059-7794/humuann.htm.
  17. Hamill OP, Marty, A, Neher E, Sakmann B, Sigworth FJ. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch. 1981;391:85–100.[Medline] [Order article via Infotrieve]
  18. Hagiwara N, Irisawa H, Kasanuki H, Hosoda S. Background current in the sino-atrial node cells of the rabbit heart. J Physiol. 1992a;448:53–72.
  19. Matsuda N, Hagiwara N, Shoda M, Kasanuki H, Hosoda S. Enhancement of the L-type Ca2+ current by mechanical stimulation in single rabbit cardiac myocytes. Circ Res. 1996;78:650–659.[Abstract/Free Full Text]
  20. Liman ER, Tytgat J, Hess P. Subunit stoichiometry of a mammalian K+ channel determined by construction of multimeric cDNAs. Neuron. 1992;9:861–871.[Medline] [Order article via Infotrieve]
  21. Rudy B, Iverson LE. Methods in Enzymology: Ion Channels. New York, NY: Academic Press; 1992;207:225–338.
  22. Zhou Z, Gong Q, Epstein ML, January CT. HERG channel dysfunction in human long QT syndrome: intracellular transport and functional defects. J Biol Chem. 1998;273:21061–21066.[Abstract/Free Full Text]
  23. Smith PL, Baukrowitz T, Yellen G. The inward rectification mechanism of the HERG cardiac potassium channel. Nature. 1996;379:833–836.
  24. Nakajima T, Furukawa T, Tanaka T, Katayama Y, Nagai R, Nakamura Y, Hiraoka M. Novel mechanism of HERG current suppression in LQT2: shift in voltage dependence of HERG inactivation. Circ Res. 1998;83:415–422.[Abstract/Free Full Text]
  25. Denning GM, Anderson MP, Amara JF, Marshall J, Smith AE, Welsh MJ. Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature sensitive. Nature. 1992;358:761–764.Mutations in the human ether-a-go-go–related gene (HERG) cause abnormal cardiac repolarization, leading to arrhythmia by disrupting IKr. Studies of mutant HERG channels in heterologous systems indicate that mechanisms underlying mutant channel phenotypes are varied. We recently reported a novel missense mutation of HERG (G601S) in a long-QT syndrome (LQTS) family. We expressed the G601S mutant channels in mammalian cells and Xenopus oocytes. This mutant produces less current than wild-type channels with no change in kinetic properties and without dominant-negative suppression of wild-type subunits. These findings suggest an additional, novel mechanism underlying chromosome 7–linked LQTS, partial expression of HERG.[Medline] [Order article via Infotrieve]



This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
P. Phartiyal, H. Sale, E. M. C. Jones, and G. A. Robertson
Endoplasmic Reticulum Retention and Rescue by Heteromeric Assembly Regulate Human ERG 1a/1b Surface Channel Composition
J. Biol. Chem., February 15, 2008; 283(7): 3702 - 3707.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
D. F. Steele, J. Eldstrom, and D. Fedida
Mechanisms of cardiac potassium channel trafficking
J. Physiol., July 1, 2007; 582(1): 17 - 26.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. M. Cordeiro, H. Barajas-Martinez, K. Hong, E. Burashnikov, R. Pfeiffer, A.-M. Orsino, Y. S. Wu, D. Hu, J. Brugada, P. Brugada, et al.
Compound Heterozygous Mutations P336L and I1660V in the Human Cardiac Sodium Channel Associated With the Brugada Syndrome
Circulation, November 7, 2006; 114(19): 2026 - 2033.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
F. Van Goor, K. S. Straley, D. Cao, J. Gonzalez, S. Hadida, A. Hazlewood, J. Joubran, T. Knapp, L. R. Makings, M. Miller, et al.
Rescue of {Delta}F508-CFTR trafficking and gating in human cystic fibrosis airway primary cultures by small molecules
Am J Physiol Lung Cell Mol Physiol, June 1, 2006; 290(6): L1117 - L1130.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C. L. Anderson, B. P. Delisle, B. D. Anson, J. A. Kilby, M. L. Will, D. J. Tester, Q. Gong, Z. Zhou, M. J. Ackerman, and C. T. January
Most LQT2 Mutations Reduce Kv11.1 (hERG) Current by a Class 2 (Trafficking-Deficient) Mechanism
Circulation, January 24, 2006; 113(3): 365 - 373.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
J. M. Nerbonne and R. S. Kass
Molecular Physiology of Cardiac Repolarization
Physiol Rev, October 1, 2005; 85(4): 1205 - 1253.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. E. Ruoho
How the Monoamine Transporter Garden Grows
Mol. Pharmacol., August 1, 2005; 68(2): 272 - 274.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
B. P. Delisle, J. K. Slind, J. A. Kilby, C. L. Anderson, B. D. Anson, R. C. Balijepalli, D. J. Tester, M. J. Ackerman, T. J. Kamp, and C. T. January
Intragenic Suppression of Trafficking-Defective KCNH2 Channels Associated with Long QT Syndrome
Mol. Pharmacol., July 1, 2005; 68(1): 233 - 240.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
J. Wan, R. Khanna, M. Sandusky, D. M. Papazian, J. C. Jen, and R. W. Baloh
CACNA1A mutations causing episodic and progressive ataxia alter channel trafficking and kinetics
Neurology, June 28, 2005; 64(12): 2090 - 2097.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. Rossenbacker, K. Mubagwa, R. J. Jongbloed, J. Vereecke, K. Devriendt, M. Gewillig, E. Carmeliet, D. Collen, H. Heidbuchel, and P. Carmeliet
Novel Mutation in the Per-Arnt-Sim Domain of KCNH2 Causes a Malignant Form of Long-QT Syndrome
Circulation, March 1, 2005; 111(8): 961 - 968.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. M. C. Jones, E. C. Roti Roti, J. Wang, S. A. Delfosse, and G. A. Robertson
Cardiac IKr Channels Minimally Comprise hERG 1a and 1b Subunits
J. Biol. Chem., October 22, 2004; 279(43): 44690 - 44694.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Kanki, S. Kupershmidt, T. Yang, S. Wells, and D. M. Roden
A Structural Requirement for Processing the Cardiac K+ Channel KCNQ1
J. Biol. Chem., August 6, 2004; 279(32): 33976 - 33983.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
L. Gouas, C. Bellocq, M. Berthet, F. Potet, S. Demolombe, A. Forhan, R. Lescasse, F. Simon, B. Balkau, I. Denjoy, et al.
New KCNQ1 mutations leading to haploinsufficiency in a general population: Defective trafficking of a KvLQT1 mutant
Cardiovasc Res, July 1, 2004; 63(1): 60 - 68.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
B. P. Delisle, B. D. Anson, S. Rajamani, and C. T. January
Biology of Cardiac Arrhythmias: Ion Channel Protein Trafficking
Circ. Res., June 11, 2004; 94(11): 1418 - 1428.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
A. Krumerman, X. Gao, J.-S. Bian, Y. F. Melman, A. Kagan, and T. V. McDonald
An LQT mutant minK alters KvLQT1 trafficking
Am J Physiol Cell Physiol, June 1, 2004; 286(6): C1453 - C1463.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. S. Chugh, O. Senashova, A. Watts, P. T. Tran, Z. Zhou, Q. Gong, J. L. Titus, and S. J. Hayflick
Postmortem molecular screening in unexplained sudden death
J. Am. Coll. Cardiol., May 5, 2004; 43(9): 1625 - 1629.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
D. Thomas, J. Kiehn, H. A Katus, and C. A Karle
Defective protein trafficking in hERG-associated hereditary long QT syndrome (LQT2): molecular mechanisms and restoration of intracellular protein processing
Cardiovasc Res, November 1, 2003; 60(2): 235 - 241.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. P. Delisle, C. L. Anderson, R. C. Balijepalli, B. D. Anson, T. J. Kamp, and C. T. January
Thapsigargin Selectively Rescues the Trafficking Defective LQT2 Channels G601S and F805C
J. Biol. Chem., September 12, 2003; 278(37): 35749 - 35754.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
E. Ficker, A. T. Dennis, L. Wang, and A. M. Brown
Role of the Cytosolic Chaperones Hsp70 and Hsp90 in Maturation of the Cardiac Potassium Channel hERG
Circ. Res., June 27, 2003; 92 (12): e87 - e100.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. A. Syme, K. L. Hamilton, H. M. Jones, A. C. Gerlach, L. Giltinan, G. D. Papworth, S. C. Watkins, N. A. Bradbury, and D. C. Devor
Trafficking of the Ca2+-activated K+ Channel, hIK1, Is Dependent upon a C-terminal Leucine Zipper
J. Biol. Chem., February 28, 2003; 278(10): 8476 - 8486.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
X.-K. Liu, A. Katchman, B. H Whitfield, G. Wan, E. M Janowski, R. L Woosley, and S. N Ebert
In vivo androgen treatment shortens the QT interval and increases the densities of inward and delayed rectifier potassium currents in orchiectomized male rabbits
Cardiovasc Res, January 1, 2003; 57(1): 28 - 36.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Paulussen, A. Raes, G. Matthijs, D. J. Snyders, N. Cohen, and J. Aerssens
A Novel Mutation (T65P) in the PAS Domain of the Human Potassium Channel HERG Results in the Long QT Syndrome by Trafficking Deficiency
J. Biol. Chem., December 6, 2002; 277(50): 48610 - 48616.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. C. R. Roti, C. D. Myers, R. A. Ayers, D. E. Boatman, S. A. Delfosse, E. K. L. Chan, M. J. Ackerman, C. T. January, and G. A. Robertson
Interaction with GM130 during HERG Ion Channel Trafficking. DISRUPTION BY TYPE 2 CONGENITAL LONG QT SYNDROME MUTATIONS
J. Biol. Chem., November 27, 2002; 277(49): 47779 - 47785.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Kupershmidt, T. Yang, S. Chanthaphaychith, Z. Wang, J. A. Towbin, and D. M. Roden
Defective Human Ether-a-go-go-related Gene Trafficking Linked to an Endoplasmic Reticulum Retention Signal in the C Terminus
J. Biol. Chem., July 19, 2002; 277(30): 27442 - 27448.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Rajamani, C. L. Anderson, B. D. Anson, and C. T. January
Pharmacological Rescue of Human K+ Channel Long-QT2 Mutations: Human Ether-a-Go-Go-Related Gene Rescue Without Block
Circulation, June 18, 2002; 105(24): 2830 - 2835.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. A. M. Smith, H.-W. Tsui, E. W. Newell, X. Jiang, X.-P. Zhu, F. W. L. Tsui, and L. C. Schlichter
Functional Up-regulation of HERG K+ Channels in Neoplastic Hematopoietic Cells
J. Biol. Chem., May 17, 2002; 277(21): 18528 - 18534.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
K. Hayashi, M. Shimizu, H. Ino, M. Yamaguchi, H. Mabuchi, N. Hoshi, and H. Higashida
Characterization of a novel missense mutation E637K in the pore-S6 loop of HERG in a patient with long QT syndrome
Cardiovasc Res, April 1, 2002; 54(1): 67 - 76.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Ficker, C. A. Obejero-Paz, S. Zhao, and A. M. Brown
The Binding Site for Channel Blockers That Rescue Misprocessed Human Long QT Syndrome Type 2 ether-a-gogo-related Gene (HERG) Mutations
J. Biol. Chem., February 8, 2002; 277(7): 4989 - 4998.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J Suppl